Microdose study for the clarification of the mechanism of non-linear pharmacokinetics of telmisartan in the range of therapeutic doses
Latest Information Update: 12 May 2016
Price :
$35 *
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 23 Jul 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 02 Feb 2011 New trial record